-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster II

Symposia: Lymphocytes and Acquired or Congenital Immunodeficiency Disorders Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 10, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

John Roy R Lozada, Atef Ali*, Abderrahman Day*, Jacob A Myers*, Ella Boytim*, Hannah Bergom*, Nicholas Zorko, MD, PhD*, Martin Felices, PhD*, Jeffrey S Miller, MD, Justin Hwang, PhD* and Frank Cichocki, PhD

Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN

Michelle P. Aranha, PhD1,2,3*, Romanos Sklavenitis-Pistofidis, MD1,2,3, Yoshinobu Konishi, MD, PhD1,2,3, Ting Wu, MS3*, Hong Yue, PhD4,5*, Elizabeth D. Lightbody, PhD1,2,3, Mahshid Rahmat, PhD1,2,3*, Michael Timonian, MD1,2,3*, Daniel L. Mallory, BS2,3*, Michael P. Agius, PhD1,2,3*, Shohreh Varmeh, PhD2*, Nang Kham Su, MSc2*, Jacqueline Perry, MPH2*, Erica M. Horowitz, BA2*, Maya Davis, BA2*, Anna Justis, PhD2*, Radosław P. Nowak, PhD4,5*, Mark Hamilton, PhD6*, Daniel Auclair, PhD6,7*, Catherine R. Marinac, PhD2, Eric Fischer, Ph.D.4,5*, Gad Getz, PhD3,8* and Irene M. Ghobrial, MD1,2,3

1Harvard Medical School, Boston, MA
2Dana-Farber Cancer Institute, Boston, MA
3Broad Institute of MIT and Harvard, Cambridge, MA
4Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
5Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA
6Multiple Myeloma Research Foundation, Norwalk, CT
7Hematology R&D, AstraZeneca, Waltham, MA
8Department of Pathology, Massachusetts General Hospital Cancer Center, Boston, MA

Anneka Allman1*, Brian Gaudette, PhD1*, Samantha Kelly1*, Nagham Alouche, PharmD, PhD2*, Leolene Carrington, PhD1*, Eric Perkey, MD, PhD3*, Riley Outen4*, Ashley Vanderbeck1*, Katlyn Lederer1*, Tanner F. Robertson, PhD5*, Janis K. Burkhardt5*, Anastasia N. Tikhonova, PhD6, Iannis Aifantis, PhD7, Ute Koch, PhD8*, Freddy Radtke, PhD9*, Burkhard Ludewig, DVM10*, Lena Tveriakhina, PhD11*, Achim Gossler, PhD12*, Christian W. Siebel, PhD13*, Daniela Gomez Atria, PhD1*, Sanjiv Luther, PhD2*, David Allman, PhD1* and Ivan Maillard14

1University of Pennsylvania, Philadelphia, PA
2University of Lausanne, Epalinges, Switzerland
3University of Michigan, Ann Arbor, MI
4University of Pennsylvania, Philadelphia
5Children's Hospital of Philadelphia, Philadelphia, PA
6Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
7Department of Pathology, NYU Grossman School of Medicine, New York, NY
8EPFL SV ISREC, Lausanne, Switzerland
9Ecole Polytechnique Fédlrale De Lausanne (EPFL), Lausanne, Switzerland
10Cantonal Hospital St.Gallen, St Gallen, Switzerland
11Harvard Medical School, Boston, MA
12Hannover Medical School, Hannover, Germany
13Genentech, South San Francisco, CA
14Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA

Audrey Le Floch-Ramondou, PhD*, George Scott*, Wen-Chi Chen*, Kirsten Nagashima*, Andrew Murphy*, Matthew Sleeman* and Jamie Orengo*

Regeneron Pharmaceuticals, Tarrytown, NY

Konstantinos Aliazis, PhD1*, Anthos Christofides, MD1,2*, Halil-Ibrahim Aksoylar, PhD1*, Rushil Shah1*, Rinku Pal, BS1*, Nikolaos Patsoukis, PhD1,3* and Vassiliki A Boussiotis, MD, PhD1

1Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
2Medicine, Yale University, New Heaven, CT
3Simcere of America, Cambridge, MA

Arghavan Ashouri, PhD1*, Pathum Kossinna1*, Xuyao Li1*, Jahin Kabir1*, Jianfan Nie1*, Artem Kushnirenko1*, Ilham Abbasi1*, Leandro Venturutti, PhD, BSc2,3, Zahi Touma, MD, PhD4,5* and Federico Gaiti, PhD1,6

1Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
2Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada
3BC CANCER, Vancouver, BC, Canada
4Division of Rheumatology, University of Toronto, Toronto, ON, Canada
5Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, ON, Canada
6Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada

Daria Vakula, MD, PhD1*, Ashley Reiland, MS, APRN, FNP-C2*, Ivan Kingyue Chinn, MD3*, Sandra Andrea Salinas, PhD4*, Alexander Patlan Nieto, PhD3*, Lisa Forbes Satter, MD5* and Carl E Allen, MD6

1Department of Pediatrics, Texas Children’s Cancer and Hematology Centers, Houston, Baylor College of Medicine, Houston, TX
2Department of Pediatrics, Texas Children’s Hospital Center for Human Immunobiology, Baylor College of Medicine, Houston, TX
3Texas Children’s Hospital Center for Human Immunobiology, Baylor College of Medicine, Houston, TX
4Department of Pediatrics, Texas Children’s Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX
5Texas Children's Hospital/Baylor College of Medicine, Houston, TX
6Baylor College of Medicine, Houston, TX

Mohamed Khalil1,2, Scott Terhune, PhD1* and Subramaniam Malarkannan, PhD1,2,3

1Microbiology & Immunology, Medical College of Wisconsin, Milwaukee, WI
2Blood Research Institute, Milwaukee, WI
3Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

Peyton E Conrey1*, Jose Campos1*, Andrea Mauracher, MD PhD1*, Samir Sayed1*, Jolan E. Walter, MD, PhD2*, Helen Su, MD PhD3*, Sara Barmettler, MD4*, Jennifer W Leiding, MD5*, Megan Cooper, MD PhD6*, Suzanne P MacFarland, MD7*, Melanie A Ruffner, MD PhD1*, Jocelyn R Farmer, MD PhD8*, V. Koneti Rao, MD9 and Sarah E Henrickson, MD PhD1*

1Department of Pediatrics, Allergy Immunology Division, Children's Hospital of Philadelphia, Philadelphia, PA
2Division of Allergy & Immunology, Department of Pediatrics, Morsani College of Medicine, University of South Florida at Johns Hopkins All Children’s Hospital, St. Petersburg, FL
3NIAID, NIH, Bethesda, MD
4Massachusetts General Hospital, Boston, MA
5Johns Hopkins University School of Medicine, Baltimore, MD
6Department of Pediatrics, Washington University, St. Louis
7Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
8Lahey Health, Boston, MA
9NIAID National Institutes of Health, Bethesda, MD

Akira Nishimura1*, Akihiro Hoshino1*, Tsubasa Okano1*, Kunihiko Moriya2*, Yuichiro Otsuka3*, Chikako Owada4,5*, Kaori Kanda6*, Keisuke Okuno7*, Takako Miyamura8, Takahiro Kamiya1*, Takeshi Isoda1*, Hidenori Ohnishi9*, Tomohiro Morio1*, Hirokazu Kanegane10*, Masatoshi Takagi, MD, PhD11 and Kohsuke Imai2*

1Tokyo Medical and Dental University, Tokyo, Japan
2National Defense Medical College, Saitama, Japan
3Chiba Kaihin Municipal Hospital, Chiba, Japan
4Chiba University Hospital, Chiba, Japan
5International University of Health and Welfare, Narita, Japan
6Gifu Municipal Hospital, Gifu, Japan
7Tottori University, Yonago, Japan
8Department of Pediatrics, Osaka University, Osaka, JPN
9Gifu University, Gifu, JPN
10Tokyo Medical and Dental Universtiy (TMDU), Tokyo, JPN
11Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan

Li Jun, MD1*, Yi Liu1*, Xia Wei2*, Zhanshu Liu, MD3*, Zailiang Yang, MD4*, Ling Liu5*, Meiyu Zhou4*, Guofa Xu, MD4*, Lanting Chen3*, Yao Ding1*, Haike Lei6*, Zailin Yang1*, Shuang Chen1*, Xiaomei Zhang, PhD1*, Yifeng Tang1*, Yan Xiong1*, Jueyin Liu1*, Dehong Huang1*, Chunyan Xiao1*, Jun Liu1*, Tao Yang1*, Ying Xiang1*, Qiying Li1*, Yingyu Nan1*, Jieping Li1*, Yong Zhang, MD, PhD2*, Yongzhong Wu, MD, PhD7* and Yao Liu, PhD, MD1

1Department of Hematology-Oncology, Chongqing University Cancer Hospital, Chongqing, China
2Department of Hematology, the Third Affiliated Hospital of Chongqing Medical University, Chongqing, China
3Department of Hematology, Yongchuan Hospital of Chongqing Medical University, Chongqing, China
4Department of Hematology and Medical Oncology, Chongqing University Fuling Hospital, Chongqing, China
5Department of Medical Laboratory, People’s Hospital of Chongqing Liang Jiang New Area, Chongqing, China
6Department of Chongqing Cancer Multi-omics Big Data Application Engineering Research Center, Chongqing University Cancer Hospital, Chongqing, China
7Department of Radiation Oncology, Chongqing University Cancer Hospital, Chongqing, China

Sizhou Feng1*, Yuping Fan2*, Sudong Zhang3*, Xiaomeng Feng, MD4*, Yuanfu Xu5* and Erlie Jiang, PhD1

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China
2State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, CAMS Key Laboratory for Prevention and Control of Hematological Disease Treatment Related Infection, Tianjin, AL, China
3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, CAMS Key Laboratory for Prevention and Control of Hematological Disease Treatment Related Infection, Tianjin, China
4State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, tianjin, China
5State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, CAMS Key Laboratory for Prevention and Control of Hematological Disease Treatment Related Infection, Tianjin, CHN

*signifies non-member of ASH